Editorial
Published on 02 Jun 2025
Editorial: Current trends in immunotherapy: from monoclonal antibodies to CAR-T cells
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2025.1633469
- 315 views
80 Publications
Volume 5 - 2025
Review
Accepted on 26 May 2025
Neural stem cells in adult neurogenesis and their therapeutic applications in neurodegenerative disorders: A concise review
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2025.1569717
- 214 views
Editorial
Published on 16 May 2025
Editorial: Epigenetics and stem cell therapy in cancer and diseases
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2025.1621093
- 641 views
Review
Published on 20 Feb 2025
Cell surface vimentin: a natural human immune response target for immunotherapy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2025.1552323
- 1,094 views
Editorial
Published on 18 Feb 2025
Editorial: Tuberculosis: host immunity, diagnostics and therapeutics
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2025.1568256
- 767 views
Review
Published on 13 Feb 2025
Epigenetic regulation of TDP-43: potential implications for amyotrophic lateral sclerosis
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2025.1530719
- 2,641 views
- 1 citation
Editorial
Published on 11 Feb 2025
Editorial: Neuroinflammatory aspects in neurological disorders
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2025.1557546
- 778 views
Volume 4 - 2024
Editorial
Published on 09 Jan 2025
Editorial: Gene therapy and genome editing for metabolic liver disorders
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1543685
- 808 views
Brief Research Report
Published on 08 Jan 2025
An artificial transcription factor that activates potent interferon-Îł expression in human Jurkat T Cells
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1492370
- 2,188 views
Original Research
Published on 06 Jan 2025
Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1487526
- 1,626 views
Opinion
Published on 27 Nov 2024
Human-specific gene ARHGAP11B—potentially an additional tool in the treatment of neurodegenerative diseases?
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1465647
- 860 views
Hypothesis and Theory
Published on 18 Sep 2024
DeltaRex-G, tumor targeted retrovector encoding a CCNG1 inhibitor, for CAR-T cell therapy induced cytokine release syndrome
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1461151
- 1,515 views
- 1 citation
Review
Published on 06 Sep 2024
Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1426454
- 2,878 views
- 3 citations
Editorial
Published on 03 Jul 2024
Editorial: Mitochondrial dysfunction affects mechano-energetic coupling in heart failure
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1433102
- 1,159 views
Original Research
Published on 29 Apr 2024
Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1389456
- 3,003 views
- 2 citations
Editorial
Published on 27 Feb 2024
Editorial: Celebrating the 200th mendel’s anniversary: gene-targeted diagnostics and therapies for cancer
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1366963
- 1,897 views